Healthcare · Drug Manufacturers - Specialty & Generic
· website
$0.02
52wk 0.02 – 0.07
Overall
45.1
Value
100.0
Growth
38.5
Health
61.5
Quality
0.0
Momentum
0.4
Dividend
50.0
Price
About Vitura Health Limited
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; Adaya, which provides hybrid formulations and Australian-cultivated products; Candor Medical, that provides care to patients; and inscape, which offers crafted formulations for individual needs. In addition, the company engages in the supply of MDMA and synthetic psilocybin for therapeutic purposes. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.
Price analytics
Returns
1 day
0.0%
1 week
0.0%
1 month
-29.6%
3 months
-29.6%
6 months
-54.8%
1 year
-71.2%
3 years
-94.6%
Risk
Volatility (1y ann.)
66.5%
Beta vs ASX 200
0.83
Sharpe (1y)
-1.59
VaR 95% (1-day)
-7.1%
Max drawdown (1y)
-73.2%
Off 1-year high
-73.2%
Technicals
RSI(14)
50
vs 50DMA
-18.5%
vs 200DMA
-48.6%
Trend
Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value100.0
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
100
Growth38.5
Revenue growth (1y)
29
Revenue CAGR (3y)
100
EPS growth (1y)
17
EPS CAGR (3y)
0
Financial Health61.5
Net debt / EBITDA
86
Interest coverage (EBIT/interest)
57
Current ratio
0
Debt / Equity
90
Quality (Profitability & Cash Flow)0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income50.0
Dividend yield (%)
100
Payout ratio
0
FCF dividend cover
—
Momentum0.4
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
2
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).